Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IFx-Hu2.0 Expanded Access Program

NCT04853602 is registered in ClinicalTrials.gov with TuHURA Biosciences, Inc. as lead sponsor.

NCT NCT04853602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04853602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IFx-Hu2.0 Expanded Access Program
Lead sponsor
TuHURA Biosciences, Inc.
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous melanoma, stage iii, cutaneous melanoma, stage iv, cutaneous squamous cell carcinoma, merkel cell carcinoma